A Study to Evaluate the Efficacy of Guselkumab in Chinese Participants With Crohn's Disease (CD)
Clinical trial NCT07310095 · RECRUITING
Trial details
- NCT number
- NCT07310095
- Sponsor
- Xian-Janssen Pharmaceutical Ltd.
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-30
- Primary completion
- 2027-09-15
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.